Chromocell Therapeutics(CHRO) - 2025 Q2 - Quarterly Results

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 18, 2025 PELTHOS THERAPEUTICS INC. (Exact name of registrant as specified in its charter) | Nevada 001-41964 | 86-3335449 | | --- | --- | | (State or other jurisdiction (Commission File Number) | (IRS Employer | | of incorporation) | Identification No.) | | 4020 Stirrup Creek Drive, Suite 110 | | | Durham, NC | ...